Eli Lilly and Company (LLY)
Net profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 10,590,000 | 5,240,400 | 6,244,800 | 5,581,700 | 6,193,700 |
Revenue | US$ in thousands | 45,042,700 | 34,124,100 | 28,541,400 | 28,318,400 | 24,539,800 |
Net profit margin | 23.51% | 15.36% | 21.88% | 19.71% | 25.24% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $10,590,000K ÷ $45,042,700K
= 23.51%
Based on the data provided, Eli Lilly and Company's net profit margin has demonstrated some fluctuations over the years. In December 31, 2020, the net profit margin was reported at 25.24%, reflecting a strong profitability for the company. However, by December 31, 2021, the net profit margin decreased to 19.71%, indicating a decline in profitability.
In the subsequent years, the net profit margin improved to 21.88% by December 31, 2022, but then dropped to 15.36% by December 31, 2023, showing volatility in the company's profitability. Nonetheless, there was a significant recovery in profitability by December 31, 2024, with the net profit margin increasing to 23.51%.
Overall, Eli Lilly and Company's net profit margin has experienced some variability, with both improvements and declines in profitability over the years. It is important for the company to closely monitor and manage its cost structure and revenue generation to ensure sustained profitability in the future.
Peer comparison
Dec 31, 2024